US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist
  • 5.840
  • +0.060+1.04%
Close Mar 25 16:00 ET
  • 5.800
  • -0.040-0.68%
Post 17:30 ET
518.57MMarket Cap-2.49P/E (TTM)

About Verve Therapeutics Company

Verve Therapeutics, Inc. is a genetic medicines company, which engages in the development of approach to the care of cardiovascular diseases. The company was founded by Burt A. Adelman, Keith J. Joung, Sekar Kathiresan, Kiran Musunuru, Anthony Philippakis, Issi Rozen, and Barry Ticho in 2018 and is headquartered in Boston, MA.

Company Profile

SymbolVERV
Company NameVerve Therapeutics
Listing DateJun 17, 2021
Issue Price19.00
Founded2018
CEODr. Sekar Kathiresan, M.D.
MarketNASDAQ
Employees274
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-617-603-0070
Websitehttp://www.vervetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Sekar Kathiresan, M.D.
  • Chief Executive Officer and Director
  • 9.32M
  • Allison Dorval
  • Chief Financial Officer and Principal Accounting Officer
  • 3.48M
  • Troy Lister, PhD
  • Chief Scientific Officer
  • --
  • Joan Nickerson
  • Chief Administrative Officer
  • --
  • Andrew D. Ashe, J.D.
  • President and Chief Operating Officer
  • --
  • Frederick Fiedorek, M.D.
  • Chief Medical Officer
  • --
  • Dr. Ourania Tatsis, PhD
  • Director; Executive Vice President and Chief Regulatory and Quality Officer of Vertex Pharmaceuticals
  • --
  • Dr. Burt A. Adelman, M.D.
  • Chairman of the Board
  • 451.88K
  • Sheila Mikhail, J.D.
  • Independent Director
  • 412.38K
  • Michael F. Maclean
  • Independent Director
  • 521.07K
  • Lonnel Coats
  • Independent Director
  • 407.38K
  • Alexander G. Cumbo
  • Independent Director
  • 405.88K
  • Dr. Krishna Yeshwant, M.D.
  • Independent Director
  • 410.88K
  • Jodie P. Morrison
  • Independent Director
  • --
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+3.50%
Adobe
ADBE
+2.32%
Ecopetrol
EC
+2.28%
Petroleo Brasileiro SA Petrobras
PBR
+2.15%
Strategy
MSTR
+1.81%

Unlock the Full List